InsiderClue
Insiders · Profile

Dorval Allison

Director at PUMA BIOTECHNOLOGY · Chief Financial Officer at Voyager Therapeutics. Filing since 21 Jan 2020. CIK 0001625110

PBYI PUMA BIOTECHNOLOGY, INC. Director · 4 trades VYGR Voyager Therapeutics, Inc. Chief Financial Officer · 3 trades
Company
Date
Role
Action
Shares
Amount
Of holding
PBYI PUMA BIOTECHNOLOGY, INC.
12 Jun 2026
Director
Sold on a plan
11,610
$83.58K
11.3%
PBYI PUMA BIOTECHNOLOGY, INC.
13 Jun 2025
Director
Sold on a plan
11,610
$39.47K
13.3%
PBYI PUMA BIOTECHNOLOGY, INC.
13 Jun 2024
Director
Sold on a plan
11,000
$37.10K
25.0%
PBYI PUMA BIOTECHNOLOGY, INC.
13 Jun 2023
Director
Sold on a plan
10,000
$34.50K
37.0%
VYGR Voyager Therapeutics, Inc.
11 Feb 2021
Chief Financial Officer
Sold, plan not stated
3,186
$24.05K
6.5%
VYGR Voyager Therapeutics, Inc.
12 Jan 2021
Chief Financial Officer
Sold, plan not stated
2,942
$25.36K
5.7%
VYGR Voyager Therapeutics, Inc.
21 Jan 2020
Chief Financial Officer
Sold, plan not stated
3,128
$41.79K
11.3%
7 decisions on file.